查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1478677

乳癌治疗市场、占有率、规模、趋势、行业分析报告：依治疗、依癌症类型、依分销管道、依地区、细分市场预测，2024-2032 年

Breast Cancer Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Chemotherapy, Hormonal Therapy, Targeted Therapy); By Cancer Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球乳癌治疗市场规模预计将达到 631.3 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

推动乳癌治疗市场向前发展的因素包括乳癌发生率上升、技术进步、个人化医疗需求不断增加、政府措施以及医疗支出不断增加。此外，不断增长的治疗药物正在推动市场竞争并吸引投资。随着研究的进展，新药和替代疗法的出现预计将推动市场的进一步成长。例如，2023 年 4 月，英国将为数千名乳癌患者提供一种针对遗传性基因突变的开创性癌症治疗方法。

免疫疗法，特别是检查点抑制剂，已显示出透过激活免疫系统识别和对抗癌细胞来治疗某些类型乳癌的前景。例如，帕博利珠单抗和纳武单抗等 PD-1 抑制剂正在进行针对三阴性乳癌 (TNBC) 的临床试验。人们也正在努力将免疫疗法与化疗和标靶疗法等其他治疗方法结合，以改善乳癌患者的预后。

随着医疗基础设施的改善，亚洲、非洲和拉丁美洲新兴市场对乳癌的认识不断提高。这些努力包括加强乳癌早期检测、诊断和治疗的措施。这些地区的可支配收入不断增加，使更多人能够获得先进的治疗，从而为乳癌治疗市场的提供者创造了巨大的成长机会。

乳癌治疗市场报告亮点

到2023 年，与标靶药物的引入相关的重大变化，例如针对参与乳癌生长和生存的其他细胞途径的新药物，在临床研究中显示出前景，将促使标靶治疗设计领域的转变主导市场。

荷尔蒙受体细分市场将在 2023 年引领市场，并且由于乳癌发病率上升，预计将保持其主导地位。

北美在全球乳癌治疗市场中占有重要的销售占有率，因为该地区乳癌发生率较高，对有效治疗方案产生了强烈需求。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球乳癌治疗市场洞察

  • 分销通路快照
  • 乳癌治疗市场动态
    • 推动者和机会
      • 世界各地的乳癌发生率正在上升
      • 个人化医疗的进展
    • 抑制因素和课题
      • 市场扩张预计将因专利到期而受到阻碍
  • PESTEL 分析
  • 乳癌治疗市场通路的趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第五章全球乳癌治疗市场：依治疗分类

  • 主要发现
  • 简介
  • 化疗
  • 荷尔蒙疗法
  • 标靶治疗
  • 免疫治疗
  • 放射治疗及手术治疗

第 6 章全球乳癌治疗市场：依癌症类型划分

  • 主要发现
  • 简介
  • 荷尔蒙受体
  • HER2 阳性
  • 其他

第七章全球乳癌治疗市场：依通路划分

  • 主要发现
  • 简介
  • 零售药局
  • 医院药房
  • 其他

第 8 章全球乳癌治疗市场：地区

  • 主要发现
  • 简介
    • 乳癌治疗市场评估：依地区划分，2019-2032 年
  • 北美
    • 北美：依疗法分类，2019-2032 年
    • 北美：依通路划分，2019-2032 年
    • 北美：以癌症类型划分，2019-2032 年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依疗法分类，2019-2032 年
    • 欧洲：依通路划分，2019-2032 年
    • 欧洲：依癌症类型划分，2019-2032 年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依疗法分类，2019-2032 年
    • 亚太地区：依通路划分，2019-2032 年
    • 亚太地区：依癌症类型划分，2019-2032 年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
  • 中东/非洲
    • 中东和非洲：依疗法分类，2019-2032 年
    • 中东与非洲：依通路划分，2019-2032 年
    • 中东和非洲：依癌症类型划分，2019-2032 年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依疗法分类，2019-2032 年
    • 拉丁美洲：依通路划分，2019-2032 年
    • 拉丁美洲：依癌症类型划分，2019-2032 年
    • 墨西哥
    • 巴西
    • 阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协定/揭露

第十章公司简介

  • Novartis AG
  • Pfizer Inc.
  • Merck KGaA
  • Janssen Pharmaceuticals, Inc
  • Celgene Corporation, Inc
  • Genzyme Corp
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca
  • AbbVie Inc
  • Bristol-Myers Squibb Company
  • Macrogenics, Inc
  • Celldex Therapeutics
  • Onyx Pharmaceuticals Inc.
Product Code: PM1534

The global Breast Cancer Therapy market size is expected to reach USD 63.13 billion by 2032, according to a new study by Polaris Market Research. The report "Breast Cancer Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Chemotherapy, Hormonal Therapy, Targeted Therapy); By Cancer Type; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The factors propelling the breast cancer therapy market forward, are the rising occurrence of breast cancer, technological advancements, heightened demand for personalized medicine, government initiatives, and augmented healthcare spending. Additionally, the expanding drug pipeline for treatment is fostering competition and attracting investment in the market. As research progresses, we can expect the emergence of new drugs and treatment alternatives to drive further market growth. For instance, in April 2023, England plans to offer thousands of breast cancer patients a pioneering oncology drug designed to target a hereditary genetic mutation.

Immunotherapy, especially checkpoint inhibitors, has demonstrated potential in treating specific types of breast cancer by activating the immune system to identify and combat cancer cells. For instance, PD-1 inhibitors like pembrolizumab and nivolumab are undergoing clinical trials for triple-negative breast cancer (TNBC), which is typically more aggressive and challenging to treat with conventional methods. There is also ongoing exploration of combining immunotherapy with other treatments, such as chemotherapy or targeted therapy, to enhance outcomes for breast cancer patients.

In emerging markets across Asia, Africa, and Latin America, there is a rising awareness of breast cancer alongside efforts to improve healthcare infrastructure. These efforts include initiatives to bolster early detection, diagnosis, and treatment of breast cancer. With increasing disposable incomes in these regions, more individuals can access and afford advanced treatments, thereby presenting substantial growth opportunities for providers of the breast cancer therapy market.

Breast Cancer Therapy Market Report Highlights

The targeted therapy design segment dominated the market in 2023, driven by significant transformation with the introduction of targeted medicines, such as novel medications that target other cellular pathways involved in the growth and survival of breast cancer are also showing promise in clinical studies.

The hormone receptor segment led the market in 2023 and is expected to maintain its dominance due to the rising incidence of breast cancer.

North America holds a significant revenue share in the global breast cancer therapy market, driven by the region experiences high incidence of breast cancer, creating a strong demand for effective treatment options.

The global key market players include Novartis AG, Pfizer Inc., Merck KGaA, Janssen Pharmaceuticals, Inc., Celgene Corporation, Inc., Genzyme Corp., F. Hoffmann-La Roche Ltd., AstraZeneca, AbbVie Inc., Bristol-Myers Squibb Company and Macrogenics, Inc.

Polaris Market Research has segmented the Breast Cancer Therapy market report based on therapy, cancer type, distribution channel, and region:

Breast Cancer Therapy, Therapy Outlook (Revenue - USD Billion, 2019 - 2032)

  • Chemotherapy
  • Hormonal Therapy
  • Aromatase Inhibitors
  • Estrogen Receptor Down regulators (ERDs)
  • Selective Estrogen Receptor Modulators (SERMs)
  • Targeted Therapy
  • Ribociclib
  • Palbociclib
  • Pertuzumab
  • Olaparib
  • Abemaciclib
  • Ado-Trastuzumab Emtansine
  • Everolimus
  • Trastuzumab
  • Others
  • Immunotherapy
  • Radiation & Surgery Therapy

Breast Cancer Therapy, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hormone Receptor
  • HER2+
  • Others

Breast Cancer Therapy, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Breast Cancer Therapy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Breast Cancer Therapy Market Insights

  • 4.1. Breast Cancer Therapy Market - Distribution Channel Snapshot
  • 4.2. Breast Cancer Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Worldwide Breast Cancer Incidence Rate
      • 4.2.1.2. Advancements in Personalized Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Patent expiry is expected to hinder market expansion
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Breast Cancer Therapy Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Breast Cancer Therapy Market, by Therapy

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • 5.3. Chemotherapy
    • 5.3.1. Global Breast Cancer Therapy Market, by Chemotherapy, by Region, 2019-2032 (USD Billion)
  • 5.4. Hormonal Therapy
    • 5.4.1. Global Breast Cancer Therapy Market, by Hormonal Therapy, by Region, 2019-2032 (USD Billion)
    • 5.4.2. Aromatase Inhibitors
      • 5.4.2.1. Global Breast Cancer Therapy Market, by Aromatase Inhibitors, by Region, 2019-2032 (USD Billion)
    • 5.4.3. Estrogen Receptor Down regulators (ERDs)
      • 5.4.3.1. Global Breast Cancer Therapy Market, by Estrogen Receptor Down regulators (ERDs), by Region, 2019-2032 (USD Billion)
    • 5.4.4. Selective Estrogen Receptor Modulators (SERMs)
      • 5.4.4.1. Global Breast Cancer Therapy Market, by Selective Estrogen Receptor Modulators (SERMs), by Region, 2019-2032 (USD Billion)
  • 5.5. Targeted Therapy
    • 5.5.1. Global Breast Cancer Therapy Market, by Targeted Therapy, by Region, 2019-2032 (USD Billion)
    • 5.5.2. Ribociclib
      • 5.5.2.1. Global Breast Cancer Therapy Market, by Ribociclib, by Region, 2019-2032 (USD Billion)
    • 5.5.3. Palbociclib
      • 5.5.3.1. Global Breast Cancer Therapy Market, by Palbociclib, by Region, 2019-2032 (USD Billion)
    • 5.5.4. Pertuzumab
      • 5.5.4.1. Global Breast Cancer Therapy Market, by Pertuzumab, by Region, 2019-2032 (USD Billion)
    • 5.5.5. Olaparib
      • 5.5.5.1. Global Breast Cancer Therapy Market, by Olaparib, by Region, 2019-2032 (USD Billion)
    • 5.5.6. Abemaciclib
      • 5.5.6.1. Global Breast Cancer Therapy Market, by Abemaciclib, by Region, 2019-2032 (USD Billion)
    • 5.5.7. Ado-Trastuzumab Emtansine
      • 5.5.7.1. Global Breast Cancer Therapy Market, by Ado-Trastuzumab Emtansine, by Region, 2019-2032 (USD Billion)
    • 5.5.8. Everolimus
      • 5.5.8.1. Global Breast Cancer Therapy Market, by Everolimus, by Region, 2019-2032 (USD Billion)
    • 5.5.9. Trastuzumab
      • 5.5.9.1. Global Breast Cancer Therapy Market, by Trastuzumab, by Region, 2019-2032 (USD Billion)
    • 5.5.10. Others
      • 5.5.10.1. Global Breast Cancer Therapy Market, by Others, by Region, 2019-2032 (USD Billion)
  • 5.6. Immunotherapy
    • 5.6.1. Global Breast Cancer Therapy Market, by Immunotherapy, by Region, 2019-2032 (USD Billion)
  • 5.7. Radiation & Surgery Therapy
    • 5.7.1. Global Breast Cancer Therapy Market, by Radiation & Surgery Therapy, by Region, 2019-2032 (USD Billion)

6. Global Breast Cancer Therapy Market, by Cancer Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 6.3. Hormone Receptor
    • 6.3.1. Global Breast Cancer Therapy Market, by Hormone Receptor, by Region, 2019-2032 (USD Billion)
  • 6.4. HER2+
    • 6.4.1. Global Breast Cancer Therapy Market, by HER2+, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Breast Cancer Therapy Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Breast Cancer Therapy Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Retail Pharmacies
    • 7.3.1. Global Breast Cancer Therapy Market, by Retail Pharmacies, By Region, 2019-2032 (USD Billion)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Global Breast Cancer Therapy Market, by Hospital Pharmacies, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Breast Cancer Therapy Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Breast Cancer Therapy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Breast Cancer Therapy Market - North America
    • 8.3.1. North America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.3.2. North America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.3.4. Breast Cancer Therapy Market - U.S.
      • 8.3.4.1. U.S.: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.3.5. Breast Cancer Therapy Market - Canada
      • 8.3.5.1. Canada: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 8.4. Breast Cancer Therapy Market - Europe
    • 8.4.1. Europe: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.4. Breast Cancer Therapy Market - UK
      • 8.4.4.1. UK: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.5. Breast Cancer Therapy Market - France
      • 8.4.5.1. France: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.6. Breast Cancer Therapy Market - Germany
      • 8.4.6.1. Germany: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.7. Breast Cancer Therapy Market - Italy
      • 8.4.7.1. Italy: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.8. Breast Cancer Therapy Market - Spain
      • 8.4.8.1. Spain: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.9. Breast Cancer Therapy Market - Netherlands
      • 8.4.9.1. Netherlands: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.4.10. Breast Cancer Therapy Market - Russia
      • 8.4.10.1. Russia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 8.5. Breast Cancer Therapy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.4. Breast Cancer Therapy Market - China
      • 8.5.4.1. China: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.5. Breast Cancer Therapy Market - India
      • 8.5.5.1. India: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.6. Breast Cancer Therapy Market - Malaysia
      • 8.5.6.1. Malaysia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.7. Breast Cancer Therapy Market - Japan
      • 8.5.7.1. Japan: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.8. Breast Cancer Therapy Market - Indonesia
      • 8.5.8.1. Indonesia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.5.9. Breast Cancer Therapy Market - South Korea
      • 8.5.9.1. South Korea: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 8.6. Breast Cancer Therapy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.4. Breast Cancer Therapy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.5. Breast Cancer Therapy Market - UAE
      • 8.6.5.1. UAE: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.6. Breast Cancer Therapy Market - Israel
      • 8.6.6.1. Israel: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.6.7. Breast Cancer Therapy Market - South Africa
      • 8.6.7.1. South Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • 8.7. Breast Cancer Therapy Market - Latin America
    • 8.7.1. Latin America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.4. Breast Cancer Therapy Market - Mexico
      • 8.7.4.1. Mexico: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.5. Breast Cancer Therapy Market - Brazil
      • 8.7.5.1. Brazil: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
    • 8.7.6. Breast Cancer Therapy Market - Argentina
      • 8.7.6.1. Argentina: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Novartis AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Pfizer Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Merck KGaA
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Janssen Pharmaceuticals, Inc
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Celgene Corporation, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Genzyme Corp
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. AstraZeneca
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. AbbVie Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Bristol-Myers Squibb Company
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Macrogenics, Inc
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Celldex Therapeutics
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Onyx Pharmaceuticals Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables

  • Table 1 Global Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 2 Global Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 3 Global Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 6 North America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 7 North America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 9 U.S.: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 12 Canada: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 15 Europe: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 18 UK: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 19 UK: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 21 France: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 22 France: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 24 Germany: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 27 Italy: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 30 Spain: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 36 Russia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 42 China: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 43 China: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 45 India: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 46 India: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 51 Japan: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 57 South Korea: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 66 UAE: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 69 Israel: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 72 South Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 75 Latin America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 78 Mexico: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 81 Brazil: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
  • Table 84 Argentina: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Breast Cancer Therapy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Cancer Type
  • Figure 7. Global Breast Cancer Therapy Market, by Cancer Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Therapy
  • Figure 9. Global Breast Cancer Therapy Market, by Therapy, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Breast Cancer Therapy Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Breast Cancer Therapy Market